Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+ memory T lymphocyte populations.
In the search for effective vaccines against intracellular pathogens such as HIV, tuberculosis and malaria, recombinant viral vectors are increasingly being used to boost previously primed T cell responses. Published data have shown prime-boost vaccination with BCG-MVA85A (modified vaccinia virus An...
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| 格式: | Journal article |
| 語言: | English |
| 出版: |
2007
|
| _version_ | 1826277401119686656 |
|---|---|
| author | Beveridge, N Price, D Casazza, J Pathan, A Sander, C Asher, T Ambrozak, DR Precopio, M Scheinberg, P Alder, N Roederer, M Koup, R Douek, D Hill, A Mcshane, H |
| author_facet | Beveridge, N Price, D Casazza, J Pathan, A Sander, C Asher, T Ambrozak, DR Precopio, M Scheinberg, P Alder, N Roederer, M Koup, R Douek, D Hill, A Mcshane, H |
| author_sort | Beveridge, N |
| collection | OXFORD |
| description | In the search for effective vaccines against intracellular pathogens such as HIV, tuberculosis and malaria, recombinant viral vectors are increasingly being used to boost previously primed T cell responses. Published data have shown prime-boost vaccination with BCG-MVA85A (modified vaccinia virus Ankara expressing antigen 85A) to be highly immunogenic in humans as measured by ex vivo IFN-gamma ELISPOT. Here, we used polychromatic flow cytometry to investigate the phenotypic and functional profile of these vaccine-induced Mycobacterium tuberculosis (M.tb) antigen 85A-specific responses in greater detail. Promisingly, antigen 85A-specific CD4(+) T cells were found to be highly polyfunctional, producing IFN-gamma, TNF-alpha, IL-2 and MIP-1beta. Surface staining showed the responding CD4(+) T cells to be relatively immature (CD45RO(+) CD27(int)CD57(-)); this observation was supported by the robust proliferative responses observed following antigenic stimulation. Furthermore, these phenotypic and functional properties were independent of clonotypic composition and epitope specificity, which was maintained through the different phases of the vaccine-induced immune response. Overall, these data strongly support the use of MVA85A in humans as a boosting agent to expand polyfunctional M.tb-specific CD4(+) T cells capable of significant secondary responses. |
| first_indexed | 2024-03-06T23:28:20Z |
| format | Journal article |
| id | oxford-uuid:6b2eebbd-762b-47fb-883c-1edd7b7e46bc |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T23:28:20Z |
| publishDate | 2007 |
| record_format | dspace |
| spelling | oxford-uuid:6b2eebbd-762b-47fb-883c-1edd7b7e46bc2022-03-26T19:02:05ZImmunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+ memory T lymphocyte populations.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:6b2eebbd-762b-47fb-883c-1edd7b7e46bcEnglishSymplectic Elements at Oxford2007Beveridge, NPrice, DCasazza, JPathan, ASander, CAsher, TAmbrozak, DRPrecopio, MScheinberg, PAlder, NRoederer, MKoup, RDouek, DHill, AMcshane, HIn the search for effective vaccines against intracellular pathogens such as HIV, tuberculosis and malaria, recombinant viral vectors are increasingly being used to boost previously primed T cell responses. Published data have shown prime-boost vaccination with BCG-MVA85A (modified vaccinia virus Ankara expressing antigen 85A) to be highly immunogenic in humans as measured by ex vivo IFN-gamma ELISPOT. Here, we used polychromatic flow cytometry to investigate the phenotypic and functional profile of these vaccine-induced Mycobacterium tuberculosis (M.tb) antigen 85A-specific responses in greater detail. Promisingly, antigen 85A-specific CD4(+) T cells were found to be highly polyfunctional, producing IFN-gamma, TNF-alpha, IL-2 and MIP-1beta. Surface staining showed the responding CD4(+) T cells to be relatively immature (CD45RO(+) CD27(int)CD57(-)); this observation was supported by the robust proliferative responses observed following antigenic stimulation. Furthermore, these phenotypic and functional properties were independent of clonotypic composition and epitope specificity, which was maintained through the different phases of the vaccine-induced immune response. Overall, these data strongly support the use of MVA85A in humans as a boosting agent to expand polyfunctional M.tb-specific CD4(+) T cells capable of significant secondary responses. |
| spellingShingle | Beveridge, N Price, D Casazza, J Pathan, A Sander, C Asher, T Ambrozak, DR Precopio, M Scheinberg, P Alder, N Roederer, M Koup, R Douek, D Hill, A Mcshane, H Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+ memory T lymphocyte populations. |
| title | Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+ memory T lymphocyte populations. |
| title_full | Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+ memory T lymphocyte populations. |
| title_fullStr | Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+ memory T lymphocyte populations. |
| title_full_unstemmed | Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+ memory T lymphocyte populations. |
| title_short | Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+ memory T lymphocyte populations. |
| title_sort | immunisation with bcg and recombinant mva85a induces long lasting polyfunctional mycobacterium tuberculosis specific cd4 memory t lymphocyte populations |
| work_keys_str_mv | AT beveridgen immunisationwithbcgandrecombinantmva85ainduceslonglastingpolyfunctionalmycobacteriumtuberculosisspecificcd4memorytlymphocytepopulations AT priced immunisationwithbcgandrecombinantmva85ainduceslonglastingpolyfunctionalmycobacteriumtuberculosisspecificcd4memorytlymphocytepopulations AT casazzaj immunisationwithbcgandrecombinantmva85ainduceslonglastingpolyfunctionalmycobacteriumtuberculosisspecificcd4memorytlymphocytepopulations AT pathana immunisationwithbcgandrecombinantmva85ainduceslonglastingpolyfunctionalmycobacteriumtuberculosisspecificcd4memorytlymphocytepopulations AT sanderc immunisationwithbcgandrecombinantmva85ainduceslonglastingpolyfunctionalmycobacteriumtuberculosisspecificcd4memorytlymphocytepopulations AT ashert immunisationwithbcgandrecombinantmva85ainduceslonglastingpolyfunctionalmycobacteriumtuberculosisspecificcd4memorytlymphocytepopulations AT ambrozakdr immunisationwithbcgandrecombinantmva85ainduceslonglastingpolyfunctionalmycobacteriumtuberculosisspecificcd4memorytlymphocytepopulations AT precopiom immunisationwithbcgandrecombinantmva85ainduceslonglastingpolyfunctionalmycobacteriumtuberculosisspecificcd4memorytlymphocytepopulations AT scheinbergp immunisationwithbcgandrecombinantmva85ainduceslonglastingpolyfunctionalmycobacteriumtuberculosisspecificcd4memorytlymphocytepopulations AT aldern immunisationwithbcgandrecombinantmva85ainduceslonglastingpolyfunctionalmycobacteriumtuberculosisspecificcd4memorytlymphocytepopulations AT roedererm immunisationwithbcgandrecombinantmva85ainduceslonglastingpolyfunctionalmycobacteriumtuberculosisspecificcd4memorytlymphocytepopulations AT koupr immunisationwithbcgandrecombinantmva85ainduceslonglastingpolyfunctionalmycobacteriumtuberculosisspecificcd4memorytlymphocytepopulations AT douekd immunisationwithbcgandrecombinantmva85ainduceslonglastingpolyfunctionalmycobacteriumtuberculosisspecificcd4memorytlymphocytepopulations AT hilla immunisationwithbcgandrecombinantmva85ainduceslonglastingpolyfunctionalmycobacteriumtuberculosisspecificcd4memorytlymphocytepopulations AT mcshaneh immunisationwithbcgandrecombinantmva85ainduceslonglastingpolyfunctionalmycobacteriumtuberculosisspecificcd4memorytlymphocytepopulations |